Visitor registration for the 23rd China International In Vitro Diagnostic Expo by CACLP is now officially open.
As part of promotional activities leading up to CACLP 2026, a series of activities took place successfully in Xiamen last week. Among them, the Xiamen Forum on Empowering the In Vitro Diagnostics Industry and Exploring New Models of Collaboration was held on 21 November 2025.
2019 CACLP Floorplan in Nanchang
2018 CACLP Floorplan In Chongqing
The 1st Chinese In Vitro Diagnostic (IVD) Industry Forum
The 2nd BodeChina In-Vitro Diagnostic Industry Forum, which is organized by ChinaAssociation of Clinical Laboratory Practice/China Association of In-vitroDiagnostics and Shanghai Bode Exhibition Business Co., Ltd, will be held onMarch 17th, 2015 at Xi
charge of conference room
leisure activities recommadation in Nanchang
contact information
The successful Conveningof the 4thBode China (International) IVD Industry Forum In the morning of March 11, hosted by China Association of In-vitro Diagnostics, the 4thBode China (International) IVD Industry Forum was held at Qingdao Intern
The 2nd Bode China In-Vitro Diagnostics (IVD) Industry forum which was hosted by Shanghai Bode Exhibition Business Co., Ltd was held in Xiamen International Exhibition Conference Center at March 17, 2015. More than 500 professors and repres
2016 March 6 th Xian 1. Forum Topic ? Chinese IVDs Innovation, Transition and Internet Plus in the New Normal. 2. Agenda Presenter Speech Time Topic Speaker Sun Yifeng 08:30-08:40 Forum chairman make opening speech Lian Xinting 08:40-09:1
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.